CSFZX | JAREX | CSFZX / JAREX | |
Total Expense Ratio | 0.84 | 1.46 | 58% |
Annual Report Gross Expense Ratio | 0.84 | 1.46 | 58% |
Fund Existence | 11 years | 16 years | - |
Gain YTD | 8.806 | 9.726 | 91% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.01B | 261M | 769% |
Annual Yield % from dividends | 2.89 | 2.29 | 126% |
Returns for 1 year | 9.08 | 9.70 | 94% |
Returns for 3 years | 10.40 | 1.37 | 761% |
Returns for 5 years | 36.16 | 10.04 | 360% |
Returns for 10 years | 48.72 | -6.27 | -776% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMVCX | 15.79 | 0.14 | +0.89% |
Goldman Sachs Small/Mid Cap Equity C | |||
FCDCX | 31.44 | 0.26 | +0.83% |
Fidelity Advisor Stock Selector Sm Cp C | |||
PHLAX | 33.09 | 0.17 | +0.52% |
PGIM Jennison Health Sciences A | |||
PISVX | 10.07 | 0.01 | +0.10% |
Victory Pioneer Intrinsic Value A | |||
FGIWX | 12.88 | -0.01 | -0.08% |
Nuveen Global Infrastructure R6 |